Logo

Natco Pharma Share Price

Natco Pharma (INR)1386.25-11   (-0.8%)

Exchange ScripsBSE524816NSENATCOPHARMISININE987B01026

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Natco Pharma Performance

Market performance
Open price1402
High1420
Volumes482349
Prev Close1386.25
Low1381.15
Closing date2025-01-02
Historical performance
1 Year High1639.00
3 Year High1639.00
5 Year High1639.00
1 Year Low805.00
3 Year Low502.00
5 Year Low402.55

Natco Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
24788
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
17.87
Dividend Yield
Dividend Yield
0.34 %

Natco Pharma Investment Returns

1 Year
68.9%
3 Years
53.2%
5 Years
123.3%
10 Years
353.2%

Natco Pharma Technicals

IndicatorsValueSignal
5-DMA1392.04Bearish
10-DMA1397.63Bearish
20-DMA1426.39Bearish
50-DMA1396.88Bearish
100-DMA1437.88Bearish
200-DMA1268.22Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters2121212121
Foreign Investors---------------
Domestic Investors2121212121
Public Investors302923251464228446207550163732
Government---1---------

Natco Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income128112859901060
Operating Profit187951040236257098
Interest192145177133
Depreciation1868163814261169
Profit Before Tax16735861920225796
Consolidated Net Profit13883715317004409
Adjusted EPS7839924

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital358365365365
Total Reserves58173483734223740676
Minority Interest---------18
Total Non-Current Liabilities610100513511429
Total Liabilities68869565745109147919
Capital Work in Progress137364312952234
Total Assets68869565745109147919

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities1211684914652988
Cash Flow from Investing Activities-10327-4771-53-1033
Cash Flow from Financing Activitie-2469-3630348-1857
Net Cash Inflow / Outflow-6809076098
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 17.87.
  • 3Y Stock Price CAGR of the stock is 14.6.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹18795 Million.
  • The company generated revenue of ₹39988 Million in the previous financial year.

Natco Pharma

1386.25-11   (-0.8%)

Investment Amount: ₹ 83545
Current Value: ₹ 138625
Performance: 65.9%
P/L: ₹ 55080
Top Gainers
SymbolChange%
RICOAUTO99.23(20%)
AMNPLST330.7(18%)
SUNDARMFIN4698.9(15%)
TRANSRAILL642.9(14%)
RIIL1207.75(11%)
Top Losers
SymbolChange%
JAICORPLTD248.4(-20%)
WEL155.86(-6%)
PETRONET327.75(-6%)
FILATFASH0.69(-6%)
3IINFOLTD31.89(-5%)
MIRCELECTR24.97(-5%)
PDMJEPAPER187.1(-5%)
HOVS81.22(-5%)
Similar stocks

Bajaj Healthcare

54.6

609.35

December 2 - January 2

Ind-Swift

47.6

31.58

December 2 - January 2

Brooks Laboratories

35.8

187.41

December 2 - January 2

Lincoln Pharma

33

846.1

December 2 - January 2

Zota Health Care

31.9

802.45

December 2 - January 2

Ind-Swift Lab.

23.5

111.05

December 2 - January 2

Lasa Supergenerics

20.2

29.7

December 2 - January 2

Medico Remedies

20.1

57.36

December 2 - January 2

Announcing Stock of the Month!

Stock of the Month
Stock of the Month